




1078–5884/00Neutrophil Activation Occurs in the Lower-limbs of Patients
Undergoing Elective Repair of Abdominal Aortic Aneurysm
M.G.A. Norwood,1* T. Horsburgh,2 M.J. Bown1 and R.D. Sayers11Department of Vascular Surgery, University of Leicester, and 2Leicester General Hospital, Leicester, UKObjectives. AAA repair is associated with a systemic inflammatory response, mediated in part by neutrophils. The aim of
this study was to determine where neutrophil activation occurs.
Methods. Blood was sampled from the femoral vein, portal vein and radial artery of 10 patients undergoing elective AAA
repair at four time-points [induction of anaesthesia (systemic sample only), pre-aortic clamp application, pre-clamp removal
and after 30 min of reperfusion]. Whole blood was analysed for the white cell count, neutrophil count, and for neutrophil
CD11b expression.
Results. The white cell count and neutrophil counts increased after aortic clamp release. Neutrophil expression of CD11b
was significantly higher in the femoral vein than the portal vein and systemic circulation during ischaemia [PZ0.001 (FV
vs. PV), PZ0.017 (FV vs. systemic)] and reperfusion [PZ0.001 (FV vs. PV), PZ0.013 (FV vs. systemic)]. There were no
significant differences in neutrophil CD11b expression between the systemic and portal vein samples at any time.
Conclusions. Ischaemia and reperfusion during abdominal aortic aneurysm repair are associated with a global increase in
the white cell count and neutrophil count, but with increased neutrophil CD11b expression only in the femoral vein. This
suggests the lower-limbs are sensitive to aortic clamp-related reperfusion injury and may fuel the inflammatory response.Keywords: Aortic aneurysm, abdominal; Sepsis syndrome; Inflammation; Antigens; CD11b; Neutrophils.Abdominal aortic aneurysm (AAA) repair is associ-
ated with an inflammatory response.1 This is thought
in part to originate as a result of aortic clamp-related
ischaemia reperfusion injury (IRI). In the majority of
patients undergoing elective AAA repair, the inflam-
matory response is transient. However, a proportion of
patients demonstrate a more marked inflammatory
response that may progress to organ failure. This is
most commonly seen in patients undergoing repair of
ruptured AAA,2 where the development of organ
failure is a frequent event, and is associated with poor
prognosis.3 Neutrophils are important mediators of
the systemic inflammatory syndrome (SIRS), sepsis
and organ failure,4 and are known to become activated
during IRI.5 As neutrophils are activated, they
upregulate their expression of the Mac-1 surface
integrin (also known as the CD11b/CD18 complex),6
which is important for neutrophil–endothelial cell
binding, and which is required for neutrophiling author. Mike Norwood, Department of Surgery,
Leicester, Robert Kilpatrick Clinical Sciences Building,
al Infirmary, Leicester LE2 7LX, UK.
: mgan2@le.ac.uk
0390+ 05 $35.00/0 q 2005 Elsevier Ltd. All rights reserrecruitment and propagation of the inflammatory
response. During AAA repair, neutrophil activation
is known to occur,7 however, the precise site where this
activation occurs is uncertain. As neutrophils are
known to become activated in response to IRI, it is
likely that neutrophil activation occurs in tissues
subjected to IRI. During AAA repair the necessity for
aortic clamping dictates that the lower-limbs are most
susceptible to IRI. The aim of this study was, therefore,
to investigate where neutrophil activation occurs
during AAA repair.Methods
Ethical approval was granted by the local ethics
committee, and consecutive patients undergoing
elective, transperitoneal repair of infrarenal abdominal
aortic aneurysms were recruited. All patients had
infrarenal aortic clamps, and all patients received a
standardised anaesthetic given by a designated vas-
cular anaesthetist. All patients gave informed consent.
Blood samples were taken from each patient atEur J Vasc Endovasc Surg 29, 390–394 (2005)
doi:10.1016/j.ejvs.2004.12.027, available online at http://www.sciencedirect.com onved.
Neutrophil Activation During AAA Repair 391induction of anaesthesia, immediately prior to aortic
clamp application, immediately prior to aortic clamp
removal (ischaemic phase) and 30 min after clamp
removal (reperfusion phase). At each of the four
stages, blood was sampled from the radial artery (via
an arterial line). Venous blood was also sampled from
the femoral vein (FV) and portal vein (PV) prior to
aortic clamp application, during ischaemia and during
reperfusion. FV sampling was performed by vene-
puncture of the common femoral vein, and PV
sampling was performed using an indwelling catheter.
This catheter was inserted into the PV via the inferior
mesenteric vein during the initial laparotomy, prior to
aneurysm sac mobilisation. It was advanced to lie
within the PV and its position was confirmed by
palpation of the PV in the free edge of the lesser
omentum. The catheter was secured in place with
vicryl ties, and kept patent by flushing with hepar-
inised saline. After each blood sample was taken, it
was immediately placed into a sterile glass blood-
collection bottle containing EDTA (BD Vacutainere,
BD Biosciences, Oxford, UK). The samples were kept
on ice until the end of the procedure, after which, the
white cell count and neutrophil count were calculated
by laboratory staff, and the amount of neutrophil
CD11b expression was calculated by flow cytometry,
using a BD Facs scanner. Briefly, 20 ml of phycoerythrin
(PE)-labelled anti-CD11b monoclonal antibody (BD
Biosciences, Oxford, UK) was added to 50 ml of whole
blood and fixed. The erythrocytes were then lysed,
leaving a precipitate of leucocytes, which were
washed and processed in the flow cytometer. Neu-
trophil CD11b expression for each sample was
calculated from the median fluorescence value. This
was then converted to be expressed as the ‘molecular
equivalents of fluorescein’ value (MEF). A PE-labelled
isotype control was processed with each sample to
calculate ‘background’ antibody binding, and this
value was subtracted from each sample value to
improve accuracy. The samples from each individual
patient were processed together (paired samples) on
the same assay. The induction sample, therefore,
acting as the baseline sample (normal control) for
each individual patient.
The data were normally distributed (assessed using
histogram plots and standard curves) and were,
therefore, expressed as means, with the standard
deviation (SD) shown in brackets. Statistical analysis
of the data was conducted using SPSS v11.1. Two-way
ANOVA methodology was used to compare differ-
ences in neutrophil CD11b expression between
locations. The least significance difference test was
used to account for multiple hypothesis testing.Results
A total of 10 patients (nine men) were recruited. Their
mean age was 74 years (SD 7.5), and the mean size of
AAA was 6.2 cm in diameter (SD 1.06). Two patients
had aneurysmal involvement of the iliac arteries,
necessitating the use of bifurcated grafts. The mean
operation time was 164 (SD 38) minutes, and the mean
aortic clamp time was 62 (SD 13) minutes. Intra-
operatively, patients required a mean volume replace-
ment of crystalloid and/or colloid of 5.9 (SD 2.0) litres,
and a mean red cell transfusion of 1.3 (SD 1.5) units.
Post-operatively patients had a mean ITU stay of 2.1
(SD 1.4) days, and a mean hospital stay of 13 (SD 5)
days. The mean POSSUM8 score was calculated as 37
(SD 6). No patients died post-operatively.
The systemic white cell count (WCC) and neutro-
phil counts (NC) increased steadily throughout the
procedure. Neutrophils increased from 3.3!109/l (SD
1.5) at induction, to 6.5!109/l (SD 3.5) at reperfusion.
The neutrophil count was very similar at all three
locations (Fig. 1).
Neutrophil expression of CD11b was greater in the
FV than the systemic and portal circulations, during
the pre-clamp, ischaemia and reperfusion stages (Fig. 2).
This was increasingly evident, when the CD11b plot
was expressed as the mean change in CD11b
expression from baseline (Fig. 3).
Statistical analysis of these results demonstrated
that the neutrophil CD11b expression in the femoral
vein was significantly higher than that of the portal
vein prior to clamping (PZ0.006, 95% CI for the
difference 1631–8478), during ischaemia (PZ0.001,
95% CI for the difference 2870–9411) and reperfusion
(PZ0.001, 95% CI for the difference 3337–10034). The
femoral vein neutrophil CD11b expression was also
significantly higher than systemic neutrophil CD11b
expression during ischaemia (PZ0.017, 95% CI for the
difference 813–7355) and reperfusion (PZ0.013, 95%
CI for the difference 1021–7718).
It was of interest to note that neutrophil CD11b
expression in the femoral vein was high prior to aortic
clamping. Therefore, a further group of patients (nZ6)
undergoing AAA repair had blood samples taken
from the radial artery and femoral vein at induction of
anaesthesia, in order to examine whether neutrophils
in the legs expressed greater baseline levels of CD11b
than neutrophils in the systemic circulation. Statistical
analysis of this data did not demonstrate any
significant difference (PZ0.20, Student’s t-test) in the
neutrophil CD11b expression between the systemic
and femoral circulations (Fig. 4), thereby suggesting
that neutrophils were becoming activated in the legs atEur J Vasc Endovasc Surg Vol 29, April 2005
Fig. 1. Graph displaying the change in the mean neutrophil
count (NC) for AAA patients, during the four stages, at each
location (systemic, femoral vein (FV) and portal vein (PV)).
Fig. 3. Graphical display of the change from baseline values
of the mean CD11b molecular equivalents (ME) value minus
the molecular equivalents value of the isotype control (ITC)
for AAA patients (nZ10). Femoral vein neutrophil CD11b
expression was significantly higher than that of the portal
vein prior to clamping (PZ0.006, 95% Cl for the difference
1631 to 8478), during ischaemia (PZ0.001, 95% CI for the
difference 2870 to 9411) and reperfusion (PZ0.001, 95% CI
for the difference 3337 to 10034). The femoral vein neutrophil
M. G. A. Norwood et al.392some time-point between induction of anaesthesia and
application of the aortic clamp.CD11b expression was also significantly higher than the
systemic neutrophil CD11b expression during ischaemia
(PZ0.017, 95% CI for the difference 813 to 7355) and
reperfusion (PZ0.013, 95% CI for the difference 1021 to
7718).Discussion
The results from this study demonstrate that neutro-
phil Mac-1 expression in the femoral vein increased
significantly during AAA repair, and was expressed at
higher levels than in the portal vein and systemic
circulation. Neutrophil Mac-1 expression was also
shown to decrease markedly in the portal circulation
during the procedure. This data would, therefore,
imply that neutrophil activation occurs within the legs
during AAA repair.
To date, no similar study of neutrophil activation,
using regional blood sampling techniques has been
conducted, and therefore, direct comparison of results
with other research is not possible. However, a small
number of studies investigating the neutrophil
responses to AAA repair in general have been
conducted. Barry et al.7 demonstrated a small butFig. 2. Graphical display of the mean CD11b molecular
equivalents (ME) value minus the molecular equivalents
value of the isotype control (ITC) for AAA patients (nZ10).
Eur J Vasc Endovasc Surg Vol 29, April 2005significant rise in neutrophil CD11b expression in vena
cava blood after 5 min of lower limb reperfusion in
patients undergoing AAA repair. The systemic CD11b
expression decreased at this point, however, with
further decreases in CD11b expression in both caval
and systemic samples at 40 min of reperfusion.
Interestingly, the total neutrophil count increased
during the procedure (in similarity to the findings of
this study), as did the neutrophil respiratory burstFig. 4. Graphical display of the mean CD11b-ITC values for
all patients (nZ6), for blood samples taken from the systemic
circulation and femoral vein (FV). The centre points
represent the mean values and the whiskers represent the
95% confidence intervals (95% CI).
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that the apparent disparity between venous and
arterial neutrophil CD11b expression may be due to
the removal of activated neutrophils by the lungs. A
similar hypothesis has also been suggested by Pater-
son et al.9 who demonstrated an arterial–venous
difference in neutrophil count and neutrophil activity
across the lungs, suggesting neutrophil pulmonary
trapping.
One further interesting point from the paper by
Barry et al.7 which is not discussed, is a disparity
between the findings of an increasing number of
neutrophils with greater respiratory burst activity on
one hand, compared with a decreasing CD11b
expression on the other. This result appears somewhat
contradictory, as an increasing number of neutrophils
that are more ‘active’ (as assessed by their increasing
respiratory burst activity) express less CD11b. One
explanation for this is that the more active neutrophils
bind to other compounds more avidly (e.g. products of
the inflammatory response such as soluble ICAM-1
and 2, iC3b and iC4b) via their increasing number of
Mac-1 integrins. This may then render the Mac-1
binding domain saturated so that fluorescence-
labelled antibody probes are no longer able to bind
to Mac-1, thereby giving a falsely low result (allosteric
hindrance). This theory has been alluded to by other
authors,10 who have demonstrated decreases in both
neutrophil CD11b expression and plasma levels of
sICAM-1 during reperfusion in the systemic blood
samples of patients undergoing femorodistal bypass
surgery.
In order to attempt to address the theory that the
quantification of neutrophil CD11b in blood may give
inaccurate results due to either tissue neutrophil
sequestration or allosteric hindrance, Swartbol et al.11
performed a series of experiments adding systemic
plasma from patients undergoing open and endovas-
cular repair of AAA to normal donor leucocytes. The
authors demonstrated that the addition of plasma
taken from AAA patients prior to clamping, upon
clamp removal and at 60 min after clamp removal
(endovascular patients only) led to an increase in
CD11b expression in the ‘normal’ donor granulocytes.
These results are interesting in two ways. Firstly, the
plasma from endovascular patients caused greater
CD11b expression. This is somewhat unexpected as
endovascular repair is generally accepted to be
associated with less of an inflammatory response
than open repair.12 It could be theoretically possible,
however, that the reperfusion plasma from patients
undergoing open repair of AAA also contains higher
levels of sICAM-1, thereby leading to allosteric
hindrance. The second interesting finding from thisstudy was that granulocyte CD11b expression
increased in both groups prior to the application of
the aortic clamp, although it is not stated whether this
increase from baseline was significant. This finding is
in keeping with the data from this study, and may
indicate that neutrophil activation can result from
surgical trauma alone, as proposed by other authors.
The results from this study raise a number of
interesting and important issues. Firstly, the question
of why neutrophil activation occurs in the lower-
limbs. Neutrophils are known to be activated by IRI,5
and because of this it has been previously assumed
that neutrophil activation during AAA repair occurs
secondarily to IRI. Indeed, previous researchers have
demonstrated histologically that neutrophils are acti-
vated during AAA repair secondarily to IRI.13 How-
ever, the fact that neutrophils in this study
demonstrated an increase in CD11b expression even
prior to aortic clamping raises the question of the
importance of IRI per se with respect to neutrophil
activation in patients undergoing elective AAA repair.
This finding was also observed by Swartbol et al.11 It is
possible that the neutrophil activation during AAA
repair occurs secondarily to surgical trauma per se, or
may be caused by micro-emboli to the lower-limbs
during aneurysm mobilisation. Another interesting
result from this study was the relative decrease in
neutrophil CD11b expression in the portal vein. This is
especially apparent, as previous work has suggested
that it may be the gastrointestinal tract and not the
lower-limbs that is the important mediator of inflam-
mation during AAA repair.14 These results may,
therefore, support the theory of allosteric hindrance,
or alternately indicate that the most activated neutro-
phils are adhering to the vascular endothelium in the
gastrointestinal tract and leaving the portal circula-
tion, resulting in a relatively lower neutrophil CD11b
expression in the portal circulation.
In summary, the results from this study indicate
that neutrophil activation occurs within the legs of
patients undergoing AAA repair, although it is unclear
whether this is due to IRI. In light of the well-
established contribution of activated neutrophils to
the inflammatory response, local blockade of neutro-
phil Mac-1 within the legs may provide a mechanism
of attenuation of the inflammatory response with
subsequent improvement in mortality and morbidity.References
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